186 related articles for article (PubMed ID: 26259316)
1. Tc 99m Sestamibi Scanning in Multiple Myeloma--a New look with SPECT-CT.
Luthra K; Bhave A; Lele RD
J Assoc Physicians India; 2014 Sep; 62(9):801-12. PubMed ID: 26259316
[TBL] [Abstract][Full Text] [Related]
2. Detection of focal myeloma lesions by technetium-99m-sestaMIBI scintigraphy.
Catalano L; Pace L; Califano C; Pinto AM; De Renzo A; Di Gennaro F; Del Vecchio S; Fonti R; Salvatore M; Rotoli B
Haematologica; 1999 Feb; 84(2):119-24. PubMed ID: 10091409
[TBL] [Abstract][Full Text] [Related]
3. [18F-FDG PET/CT and 99mTc-MIBI scintigraphy in evaluation of patients with multiple myeloma and monoclonal gammopathy of unknown significance: comparison of methods].
Myslivecek M; Bacovský J; Scudla V; Koranda P; Minarík J; Buriánková E; Formánek R; Zapletalová J
Klin Onkol; 2010; 23(5):325-31. PubMed ID: 21061682
[TBL] [Abstract][Full Text] [Related]
4. 99mTc-sestamibi imaging and bone marrow karyotyping in the assessment of multiple myeloma and MGUS.
Giovanella L; Taborelli M; Ceriani L; Zucca E; Cavalli F; Delaloye AB
Nucl Med Commun; 2008 Jun; 29(6):535-41. PubMed ID: 18458600
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m-sestamibi scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease.
Balleari E; Villa G; Garrè S; Ghirlanda P; Agnese G; Carletto M; Clavio M; Ferrando F; Gobbi M; Mariani G; Ghio R
Haematologica; 2001 Jan; 86(1):78-84. PubMed ID: 11146575
[TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
[TBL] [Abstract][Full Text] [Related]
7. ¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.
Dammacco F; Rubini G; Ferrari C; Vacca A; Racanelli V
Clin Exp Med; 2015 Feb; 15(1):1-18. PubMed ID: 25218739
[TBL] [Abstract][Full Text] [Related]
8. Staging and therapy monitoring of multiple myeloma by 99mTc-sestamibi scintigraphy: a five year single center experience.
Villa G; Balleari E; Carletto M; Grosso M; Clavio M; Piccardo A; Rebella L; Tommasi L; Morbelli S; Peschiera F; Gobbi M; Ghio R
J Exp Clin Cancer Res; 2005 Sep; 24(3):355-61. PubMed ID: 16270521
[TBL] [Abstract][Full Text] [Related]
9. Whole-body (18)F-FDG PET identifies high-risk myeloma.
Durie BG; Waxman AD; D'Agnolo A; Williams CM
J Nucl Med; 2002 Nov; 43(11):1457-63. PubMed ID: 12411548
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Tc-99m sestamibi and F-18 FDG-PET in the assessment of multiple myeloma.
Hung GU; Tsai CC; Tsai SC; Lin WY
Anticancer Res; 2005; 25(6C):4737-41. PubMed ID: 16334169
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99m-sestamibi scintigraphy: an alternative approach for diagnosis and follow-up of active myeloma lesions after high-dose chemotherapy and autologous stem cell transplantation.
Svaldi M; Tappa C; Gebert U; Bettini D; Fabris P; Franzelin F; Osele L; Mitterer M
Ann Hematol; 2001 Jul; 80(7):393-7. PubMed ID: 11529464
[TBL] [Abstract][Full Text] [Related]
12. 99mTc-sestamibi SPECT/CT and 18F-FDG-PET/CT have similar performance but different imaging patterns in newly diagnosed multiple myeloma.
Mosci C; Pericole FV; Oliveira GB; Delamain MT; Takahashi MES; Carvalheira JBC; Etchebehere ECSC; Santos AO; Miranda ECM; Lima MCL; Amorim BJ; de Souza CA; Lorand-Metze I; Ramos CD
Nucl Med Commun; 2020 Oct; 41(10):1081-1088. PubMed ID: 32732603
[TBL] [Abstract][Full Text] [Related]
13. Technetium-99m 2-methoxy-isobutyl-isonitrile uptake scintigraphy in detection of the bone marrow infiltration in multiple myeloma: correlation with MRI and other prognostic factors.
Erten N; Saka B; Berberoglu K; Turkmen C; Unal S; Bakir B; Yekeler E; Besisik SK
Ann Hematol; 2007 Nov; 86(11):805-13. PubMed ID: 17684742
[TBL] [Abstract][Full Text] [Related]
14. Tc99m-sestaMIBI uptake in nonsecretory multiple myeloma.
Catalano L; Andretta C; Pace L; Del Vecchio S; Salvatore B; De Rosa G; Buonanno MT; Paone G; Rotoli B
Hematology; 2005 Aug; 10(4):335-8. PubMed ID: 16085547
[TBL] [Abstract][Full Text] [Related]
15. Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scans.
Mele A; Offidani M; Visani G; Marconi M; Cambioli F; Nonni M; Catarini M; Brianzoni E; Berbellini A; Ascoli G; Brunori M; Agostini V; Corvatta L; Isidori A; Spinelli A; Gradari M; Leoni P
Br J Haematol; 2007 Mar; 136(5):729-35. PubMed ID: 17233770
[TBL] [Abstract][Full Text] [Related]
16. Value of Tc-99m sestamibi scintigraphy in the detection of bone lesions in multiple myeloma: comparison with Tc-99m methylene diphosphonate.
Alexandrakis MG; Kyriakou DS; Passam F; Koukouraki S; Karkavitsas N
Ann Hematol; 2001 Jun; 80(6):349-53. PubMed ID: 11475149
[TBL] [Abstract][Full Text] [Related]
17. A comparison of fluorine-18 fluoro-deoxyglucose PET and technetium-99m sestamibi in assessing patients with multiple myeloma.
Mileshkin L; Blum R; Seymour JF; Patrikeos A; Hicks RJ; Prince HM
Eur J Haematol; 2004 Jan; 72(1):32-7. PubMed ID: 14962260
[TBL] [Abstract][Full Text] [Related]
18. Combined use of 99mTc-sestamibi and 99mTc-V-DMSA in the assessment of chemotherapy effectiveness in patients with multiple myeloma.
Koutsikos J; Athanasoulis T; Anagnostopoulos A; Velidaki A; Passadi M; Dimopoulos MA; Zerva C
J Nucl Med; 2005 Jun; 46(6):978-82. PubMed ID: 15937309
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study.
Fonti R; Pace L; Cerchione C; Catalano L; Salvatore B; De Luca S; Pane F; Salvatore M; Del Vecchio S
Clin Nucl Med; 2015 Apr; 40(4):303-8. PubMed ID: 25608167
[TBL] [Abstract][Full Text] [Related]
20. Scintigraphy using (99m)Tc-MIBI (sestamibi), a sensitive parameter of activity of multiple myeloma.
Bacovsky J; Scudla V; Myslivecek M; Nekula J; Vytrasová M
Neoplasma; 2005; 52(4):302-6. PubMed ID: 16059646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
